Survival analysis showed that a higher expression of CD147 was significantly associated with shorter disease-free survival (DFS) and overall survival (OS), whereas YIPF2 expression was slightly associated with HCC survival (Fig. 3c, d). The gene discussed is BSG; the disease is hepatocellular carcinoma.